- Home
- RAPT vs CFBK Comparison
RAPT vs CFBK Comparison
Compare RAPT & CFBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAPT
- CFBK
- Stock Information
- Founded
- RAPT 2015
- CFBK 1892
- Country
- RAPT United States
- CFBK United States
- Employees
- RAPT N/A
- CFBK N/A
- Industry
- RAPT Biotechnology: Pharmaceutical Preparations
- CFBK Major Banks
- Sector
- RAPT Health Care
- CFBK Finance
- Exchange
- RAPT Nasdaq
- CFBK Nasdaq
- Market Cap
- RAPT 194.2M
- CFBK 159.5M
- IPO Year
- RAPT 2019
- CFBK 1998
- Fundamental
- Price
- RAPT $26.62
- CFBK $24.10
- Analyst Decision
- RAPT Buy
- CFBK Buy
- Analyst Count
- RAPT 6
- CFBK 1
- Target Price
- RAPT $34.17
- CFBK $29.00
- AVG Volume (30 Days)
- RAPT 180.1K
- CFBK 37.8K
- Earning Date
- RAPT 11-11-2025
- CFBK 10-29-2025
- Dividend Yield
- RAPT N/A
- CFBK 1.32%
- EPS Growth
- RAPT N/A
- CFBK 36.66
- EPS
- RAPT N/A
- CFBK 2.77
- Revenue
- RAPT N/A
- CFBK $52,793,000.00
- Revenue This Year
- RAPT N/A
- CFBK $39.98
- Revenue Next Year
- RAPT N/A
- CFBK $10.47
- P/E Ratio
- RAPT N/A
- CFBK $8.77
- Revenue Growth
- RAPT N/A
- CFBK 20.91
- 52 Week Low
- RAPT $5.67
- CFBK $19.23
- 52 Week High
- RAPT $27.74
- CFBK $31.17
- Technical
- Relative Strength Index (RSI)
- RAPT 89.76
- CFBK 40.15
- Support Level
- RAPT $18.08
- CFBK $24.10
- Resistance Level
- RAPT $21.29
- CFBK $25.13
- Average True Range (ATR)
- RAPT 1.91
- CFBK 0.44
- MACD
- RAPT 0.91
- CFBK -0.09
- Stochastic Oscillator
- RAPT 92.12
- CFBK 3.95
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
About CFBK CF Bankshares Inc.
CF Bankshares Inc is engaged in the provision of a variety of financial services. It provides personalized business banking products and services, including commercial loans and leases, commercial and residential real estate loans, equipment leasing, SBA loans and treasury management depository services. The revenues are derived principally from the interest and fees on loans originated and noninterest income generated on the sale of loans.